Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Sezary Syndrome
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Sezary Syndrome
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Sezary Syndrome
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, T-Cell » Lymphoma, T-Cell, Cutaneous » Sezary Syndrome
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Sezary Syndrome
Description
A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells). MeSH
Hierarchy View
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (2)
Phase 1 Indicated Drugs (45)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (47)
Cancer and Leukemia Group B (CALGB)
Cancer Immunotherapy Trials Network
Case Western Reserve University
City of Hope National Medical Center
James Graham Brown Cancer Center
Johannes Wesling Klinikum, Minden, Germany
Karl Landsteiner Private University of Health Sciences
Latin American Cooperative Onco-Haematology Group - Peru
Organization Involved with Phase 1 Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.